809273-66-3

Basic information

• Product Name: methyl {[(4,4-difluorocyclohexyl)methanol]amino}-3-nitrobenzoate
• Synonyms: methyl {[(4,4-difluorocyclohexyl)methanol]amino}-3-nitrobenzoate
• CAS NO: 809273-66-3
• Molecular Weight: 328.316
• Mol File: 809273-66-3.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: methyl {[(4,4-difluorocyclohexyl)methanol]amino}-3-nitrobenzoate(CAS DataBase Reference)
• NIST Chemistry Reference: methyl {[(4,4-difluorocyclohexyl)methanol]amino}-3-nitrobenzoate(809273-66-3)
• EPA Substance Registry System: methyl {[(4,4-difluorocyclohexyl)methanol]amino}-3-nitrobenzoate(809273-66-3)

Safety Data

• Hazardous Substances Data: 809273-66-3(Hazardous Substances Data)

Upstream product

• 809273-65-2 (4,4-difluorocyclohexane)methylamine hydrochloride 
• 329-59-9 4-fluoro-3-nitro-benzoic acid methyl ester 

Downstream Products

• 960390-74-3 1-({2-tert-butyl-1-[(4,4-difluorocyclohexyl)methyl]-1H-benzimidazol-5-yl}carbonyl)-N-cyclobutylpiperidine-4-carboxamide trifluoroacetate 
• 960390-76-5 1-({2-tert-butyl-1-[(4,4-difluorocyclohexyl)methyl]-1H-benzimidazol-5-yl}carbonyl)-N-isoxazol-3-ylpiperidine-4-carboxamide trifluoroacetate 
• 960391-08-6 N-[1-({2-tert-butyl-1-[(4,4-difluorocyclohexyl)methyl]-1H-benzimidazol-5-yl}carbonyl)piperidin-4-yl]cyclopropanecarboxamide trifluoroacetate 
• 960391-12-2 4-({2-tert-butyl-1-[(4,4-difluorocyclohexyl)methyl]-1H-benzimidazol-5-yl}carbonyl)-N-cyclopropylpiperazine-1-carboxamide trifluoroacetate 
• 960390-86-7 1-({2-tert-butyl-1-[(4,4-difluorocyclohexyl)methyl]-1H-benzimidazol-5-yl}carbonyl)-N-cyclopropylpyrrolidine-3-carboxamide trifluoroacetate 
• 960390-72-1 N-(tert-butyl)-1-({2-tert-butyl-1-[(4,4-difluorocyclohexyl)methyl]-1H-benzimidazol-5-yl}carbonyl)piperidine-4-carboxamide trifluoroacetate 
• 960391-14-4 2-tert-butyl-5-{[4-(cyclopropylcarbonyl)piperazin-1-yl]carbonyl}-1-[(4,4-difluorocyclohexyl)methyl]-1H-benzimidazole trifluoroacetate 
• 960391-06-4 2-[1-({2-tert-butyl-1-[(4,4-difluorocyclohexyl)methyl]-1H-benzimidazol-5-yl}carbonyl)azetidin-3-yl]-N-cyclopropylacetamide trifluoroacetate 
• 960390-64-1 1-({2-tert-butyl-1-[(4,4-difluorocyclohexyl)methyl]-1H-benzimidazol-5-yl}carbonyl)-N-ethylpiperidine-3-carboxamide trifluoroacetate 
• 960390-68-5 1-({2-tert-butyl-1-[(4,4-difluorocyclohexyl)methyl]-1H-benzimidazol-5-yl}carbonyl)-N-ethylpiperidine-4-carboxamide trifluoroacetate 
• 960390-70-9 1-({2-tert-butyl-1-[(4,4-difluorocyclohexyl)methyl]-1H-benzimidazol-5-yl}carbonyl)-N-methylpiperidine-4-carboxamide trifluoroacetate 
• 960391-36-0 tert-butyl [1-({2-tert-butyl-1-[(4,4-difluorocyclohexyl)methyl]-1H-benzimidazol-5-yl}carbonyl)piperidin-4-yl]carbamate 
• 960391-37-1 tert-butyl 4-({2-tert-butyl-1-[(4,4-difluorocyclohexyl)methyl]-1H-benzimidazol-5-yl}carbonyl)piperazine-1-carboxylate 
• 960391-50-8 C₂₆H₃₅F₂N₃O₃ 

Relevant articles and documents

BENZIMIDAZOLE DERIVATIVES WHICH ARE TO BE USED AS ANTAGONIST FOR THE CB1-RECEPTOR

Compounds of formula I or pharmaceutically acceptable salts thereof: wherein X, A, R1, R2, R3 and R4 are as defined in the specification as well as salts and pharmaceutical compositions including the compounds are prepared. They are useful in therapy, in particular in the management of pain.